নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 30 mg/3ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrtae, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 350 mg/35ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrtae, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 50 mg/5ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) - concentrate for injection - 500 mg/50ml - active: calcium folinate pentahydrate 10.8 mg/ml (as 12.71 mg/ml of calcium folinate pentahydrate, equivalent to 10 mg/ml folinic acid) excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - as rescue therapy to reduce toxicity following high-dose methotrexate therapy. has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions overdosage of methotrexate and in impaired methotrexate elimination reducing the toxicity and circumventing the effect of folic acid antagonists

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - epirubicin hydrochloride 2 mg/ml;   - solution for injection - 2 mg/ml - active: epirubicin hydrochloride 2 mg/ml   excipient: hydrochloric acid sodium chloride water for injection - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, and superficial bladder cancer (tis, ta). in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - rituximab 10 mg/ml - concentrate for infusion - 10 mg/ml - active: rituximab 10 mg/ml excipient: citric acid monohydrate hydrochloric acid polysorbate 80 sodium chloride sodium hydroxide water for injection - latest regulatory activity

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - solifenacin succinate 10mg;   - film coated tablet - 10 mg - active: solifenacin succinate 10mg   excipient: hypromellose   iron oxide red lactose monohydrate macrogol 6000 magnesium stearate pregelatinised maize starch purified talc titanium dioxide - solifenacin sandoz is indicated for the treatment of unstable bladder with symptoms of increased urinary urgency, frequent miturition, and/or urge incontinence.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - solifenacin succinate 5mg;   - film coated tablet - 5 mg - active: solifenacin succinate 5mg   excipient: hypromellose   iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate pregelatinised maize starch purified talc titanium dioxide - solifenacin sandoz is indicated for the treatment of unstable bladder with symptoms of increased urinary urgency, frequent miturition, and/or urge incontinence.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - mitoxantrone hydrochloride 2.3284 mg/ml equivalent to mitoxantrone 2 mg/ml. australian approved name is mitozantrone hydrochloride. - solution for injection - 2 mg/ml - active: mitoxantrone hydrochloride 2.3284 mg/ml equivalent to mitoxantrone 2 mg/ml. australian approved name is mitozantrone hydrochloride. excipient: glacial acetic acid hydrochloric acid nitrogen sodium acetate sodium chloride sodium sulfate water for injection - mitozantrone ebewe is indicated for the treatment of: · metastatic carcinoma of the breast · non-hodgkin's lymphoma · adult acute non-lymphocytic leukaemia (anll) · chronic myelogenous leukaemia in blast crisis

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - doxorubicin hydrochloride 2 mg/ml;   - concentrate for injection - 2 mg/ml - active: doxorubicin hydrochloride 2 mg/ml   excipient: hydrochloric acid sodium chloride water for injection - doxorubicin has been used successfully to produce regression in neoplastic conditions, e.g. acute leukaemia, wilms' tumour, neuroblastoma, soft tissue and bone sarcomas, breast carcinoma, lymphomas of both hodgkin's and non-hodgkin's type, bronchogenic (lung) carcinoma, thyroid carcinoma, hepatomas and ovarian carcinoma etc. doxorubicin is also indicated in the primary management of nonmetastatic carcinoma of the bladder (tis, t1, t2) by intravesical administration.